Literature DB >> 25590412

An ex vivo model to study hormone action in the human breast.

George Sflomos1, Marie Shamsheddin1, Cathrin Brisken2.   

Abstract

The study of hormone action in the human breast has been hampered by lack of adequate model systems. Upon in vitro culture, primary mammary epithelial cells tend to lose hormone receptor expression. Widely used hormone receptor positive breast cancer cell lines are of limited relevance to the in vivo situation. Here, we describe an ex vivo model to study hormone action in the human breast. Fresh human breast tissue specimens from surgical discard material such as reduction mammoplasties or mammectomies are mechanically and enzymatically digested to obtain tissue fragments containing ducts and lobules and multiple stromal cell types. These tissue microstructures kept in basal medium without growth factors preserve their intercellular contacts, the tissue architecture, and remain hormone responsive for several days. They are readily processed for RNA and protein extraction, histological analysis or stored in freezing medium. Fluorescence activated cell sorting (FACS) can be used to enrich for specific cell populations. This protocol provides a straightforward, standard approach for translational studies with highly complex, varied human specimens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25590412      PMCID: PMC4354520          DOI: 10.3791/52436

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

2.  Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates.

Authors:  O Yalcin-Ozuysal; M Fiche; M Guitierrez; K-U Wagner; W Raffoul; C Brisken
Journal:  Cell Death Differ       Date:  2010-04-09       Impact factor: 15.828

Review 3.  Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis.

Authors:  Laura Kass; Janine T Erler; Micah Dembo; Valerie M Weaver
Journal:  Int J Biochem Cell Biol       Date:  2007-07-19       Impact factor: 5.085

4.  MCF-7: the first hormone-responsive breast cancer cell line.

Authors:  A S Levenson; V C Jordan
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

5.  Sorting out the FACS: a devil in the details.

Authors:  William C Hines; Ying Su; Irene Kuhn; Kornelia Polyak; Mina J Bissell
Journal:  Cell Rep       Date:  2014-03-13       Impact factor: 9.423

6.  Age at first birth and breast cancer risk.

Authors:  B MacMahon; P Cole; T M Lin; C R Lowe; A P Mirra; B Ravnihar; E J Salber; V G Valaoras; S Yuasa
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.

Authors:  J Dinny Graham; Patricia A Mote; Usha Salagame; Jessica H van Dijk; Rosemary L Balleine; Lily I Huschtscha; Roger R Reddel; Christine L Clarke
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

8.  'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer.

Authors:  M C Pike; M D Krailo; B E Henderson; J T Casagrande; D G Hoel
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

9.  Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors:  Valerie Beral
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

Review 10.  ER and PR signaling nodes during mammary gland development.

Authors:  Tamara Tanos; Lucia Rojo; Pablo Echeverria; Cathrin Brisken
Journal:  Breast Cancer Res       Date:  2012-07-19       Impact factor: 6.466

View more
  2 in total

Review 1.  Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.

Authors:  Shawna B Matthews; Carol A Sartorius
Journal:  Horm Cancer       Date:  2016-10-28       Impact factor: 3.869

2.  Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation.

Authors:  Marie Shamseddin; Fabio De Martino; Céline Constantin; Valentina Scabia; Anne-Sophie Lancelot; Csaba Laszlo; Ayyakkannu Ayyannan; Laura Battista; Wassim Raffoul; Marie-Christine Gailloud-Matthieu; Philipp Bucher; Maryse Fiche; Giovanna Ambrosini; George Sflomos; Cathrin Brisken
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.